Seelos Therapeutics Inc (SEEL)
Market Closed
18 Nov, 20:00
OTC PINK OTC PINK Primary $
0. 37
+0.37
+73,899.997%
$
214.97K Market Cap
- P/E Ratio
- Div Yield
350 Volume
-4.09 Eps
$ 0
Previous Close Investors:
Want to track SEEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seelos Therapeutics Inc (SEEL) Statistics
Valuation metrics
Market Cap 214.97K
Enterprise value 11.45M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.1
Price/Book (mrq) -0.05
Enterprise Value/Revenue 5.2
Enterprise Value/EBITDA -0.3
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.37
52-Week high 0.37
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 16 May 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.2%
Operating margin -18.38%
Operational effectiveness
Return on assets -6.99%
Return on equity 1.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) -0.42
Current ratio (mrq) 0.14%
Book value per share (mrq) -6.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
